Options Solutions, LLC Axogen, Inc. Transaction History

Options Solutions, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$14.56 - $20.11 $122,828 - $169,647	-8,436 Reduced 10.49%	72,012 $1.33 Million
Q4 2024 Feb 14, 2025	BUY	$12.47 - $17.19 $558,780 - $770,283	44,810 Added 125.74%	80,448 $1.33 Million
Q3 2024 Nov 14, 2024	BUY	$7.52 - $14.69 $267,997 - $523,522	35,638 New	35,638 $499,000

186

41.6M

86.4K

14.3K

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $1B
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Options Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Options Solutions, LLC with notifications on news.